BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7896786)

  • 1. Presentation without proteolytic cleavage of endogenous precursors in the MHC class I antigen processing pathway.
    Buchholz D; Scott P; Shastri N
    J Biol Chem; 1995 Mar; 270(12):6515-22. PubMed ID: 7896786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
    Li S; Paulsson KM; Sjögren HO; Wang P
    J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors.
    Goth S; Nguyen V; Shastri N
    J Immunol; 1996 Sep; 157(5):1894-904. PubMed ID: 8757307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.
    Hallermalm K; Seki K; Wei C; Castelli C; Rivoltini L; Kiessling R; Levitskaya J
    Blood; 2001 Aug; 98(4):1108-15. PubMed ID: 11493458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues.
    Shastri N; Serwold T; Gonzalez F
    J Immunol; 1995 Nov; 155(9):4339-46. PubMed ID: 7594593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
    Levitt JM; Howell DD; Rodgers JR; Rich RR
    Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes.
    Malarkannan S; Goth S; Buchholz DR; Shastri N
    J Immunol; 1995 Jan; 154(2):585-98. PubMed ID: 7814870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules.
    Campbell DJ; Serwold T; Shastri N
    J Immunol; 2000 Jan; 164(1):168-75. PubMed ID: 10605008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
    Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
    J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules.
    Lobigs M; Müllbacher A; Blanden RV; Hämmerling GJ; Momburg F
    Immunogenetics; 1999 Oct; 49(11-12):931-41. PubMed ID: 10501835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules.
    Morrice NA; Powis SJ
    Curr Biol; 1998 Jun; 8(12):713-6. PubMed ID: 9637924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases.
    Saveanu L; Fruci D; van Endert P
    Mol Immunol; 2002 Oct; 39(3-4):203-15. PubMed ID: 12200051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.
    Knittler MR; Alberts P; Deverson EV; Howard JC
    Curr Biol; 1999 Sep; 9(18):999-1008. PubMed ID: 10508608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAP-independent presentation of CTL epitopes by Trojan antigens.
    Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
    J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes.
    Ortmann B; Copeman J; Lehner PJ; Sadasivan B; Herberg JA; Grandea AG; Riddell SR; Tampé R; Spies T; Trowsdale J; Cresswell P
    Science; 1997 Aug; 277(5330):1306-9. PubMed ID: 9271576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER.
    Paz P; Brouwenstijn N; Perry R; Shastri N
    Immunity; 1999 Aug; 11(2):241-51. PubMed ID: 10485659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum.
    Fruci D; Niedermann G; Butler RH; van Endert PM
    Immunity; 2001 Sep; 15(3):467-76. PubMed ID: 11567636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide.
    Knuehl C; Spee P; Ruppert T; Kuckelkorn U; Henklein P; Neefjes J; Kloetzel PM
    J Immunol; 2001 Aug; 167(3):1515-21. PubMed ID: 11466372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.
    Neisig A; Roelse J; Sijts AJ; Ossendorp F; Feltkamp MC; Kast WM; Melief CJ; Neefjes JJ
    J Immunol; 1995 Feb; 154(3):1273-9. PubMed ID: 7822796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.